Skip to content

More comprehensive data is available to view on larger screen sizes. For an optimal user experience please revisit from a desktop device.

Gibson Dunn

Firm details

This firm has not yet provided any supplementary information. Please contact us for firm profiling options.

Key statistics

Ranked Practice Areas
8
Awards Won
3
Recognised Lawyers
12
Male:Female Ratio of Recognised Lawyers
8:4

Rankings

within China

Practice Area Subcategory Index Rank Ave. Tier Table
Antitrust and competition
General 7 4.0 View full ranking table
Banking and finance
Leveraged & acquisition finance 3 3.0 View full ranking table
Corporate and M&A
General 13 3.7 View full ranking table
Dispute resolution
General 13 4.0 View full ranking table
Investment funds
Private equity 1 1.0 View full ranking table
Private equity
General 8 3.0 View full ranking table
Project development
including energy and infrastructure 14 Notable View full ranking table
White collar crime
Disputes 2 2.0 View full ranking table
General 1 1.0 View full ranking table

Deals/Case awards

Total win-to-nominations ratio 1:2

Award Ratio
Corporate and M&A
China Biologic Products $4.76 billion take-private 1:1
Private equity
China Biologic Products $4.76 billion take-private 0:1

Firm awards

Total win-to-nominations ratio 2:2

Award Ratio
National awards
Private client and wealth management 1:1
Regulatory 1:1

Recognised lawyers

All data gathered from 2021 datasets. Learn more.

620

Lawyers

Gibson Dunn

Name Gender Practice Areas
{{ item.name }} {{ item.gender }}